Teva Pharmaceuticals USA, Inc. v. Amneal Pharmaceuticals LLC
1:17-cv-00992
Overview
Parties
Defendant
Amneal Pharmaceuticals Co. GmbH Operating Company
Represented By
1 Attorneys ListedDuane Morris LLP
1201 North Market Street, Suite 501
Amneal Pharmaceuticals LLC Operating Company
Represented By
1 Attorneys ListedDuane Morris LLP
1201 North Market Street, Suite 501
Plaintiff
Teva Neuroscience, Inc. Operating Company
Represented By
2 Attorneys ListedShaw Keller LLP
1105 North Market Street, 12th Floor, Wilmington, DE 19801
Teva Pharmaceutical Industries Ltd. Operating Company
Represented By
2 Attorneys ListedShaw Keller LLP
1105 North Market Street, 12th Floor, Wilmington, DE 19801
Teva Pharmaceuticals USA, Inc. Operating Company
Represented By
2 Attorneys ListedShaw Keller LLP
1105 North Market Street, 12th Floor, Wilmington, DE 19801
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360Β° Radar 25 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| πΊπΈ United States | Asserted | US Continuation / Sibling | View Official Patent → |
| πͺπΊ European Patent Office (UPC States) | European Counterpart (EP) | View Official Patent → | |
| πͺπΊ European Patent Office (UPC States) | European Counterpart (EP) | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| π PCT International (WIPO) | PCT World Application | View Official Patent → | |
| π¨π¦ Canada | Canada Counterpart | View Official Patent → | |
| π°π· South Korea | South Korea Counterpart | View Official Patent → | |
| π°π· South Korea | South Korea Counterpart | View Official Patent → | |
| π¨π³ China | China Counterpart | View Official Patent → | |
| π¨π³ China | China Counterpart | View Official Patent → | |
| π―π΅ Japan | Japan Counterpart | View Official Patent → | |
| π―π΅ Japan | Japan Counterpart | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| π°π· South Korea | South Korea Counterpart | View Official Patent → | |
| π°π· South Korea | South Korea Counterpart | View Official Patent → |
No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.
Patents Involved
There is a single patent involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US9155775
Process for manufacturing glatiramer acetate product
|
Filed: 2015-01-28
Issued: 2015-10-13
|
Active (8.2 yrs remaining)
Expires: 2035-01-28
|
Patent Enforceability & Injunction Risk Assessment
Active Threat β Patent is within enforceable statutory term; injunctive relief viable.
Standard Statutory Term β No obviousness-type double patenting noted.
Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. 4th & 8th Year Maintenance Fees Paid (12th Year Window Upcoming).
Procedural Motions & Interlocutory Orders
Total Motions
11
Dispositive
0
Granted
1
Denied
0
Pending / Review
9
Motions by Category
Key Dispositive Motions & Rulings